We know dealing with pulmonary hypertension (PH) sometimes life feels like an uphill battle, both for the patients and the caregivers. You feel like you’re not doing enough or as if the disease is taking up all your time and attention. To help you on your journey, we’ve gathered a few…
Arena Pharmaceuticals has announced positive results for ralinepag (APD811), an investigational prostacyclin receptor agonist being investigated in a Phase 2 trial to treat pulmonary arterial hypertension (PAH). Ralinepag is an oral drug that targets the prostacyclin pathway. The drug was developed for the treatment of PAH, due to its action on…
According to the Cleveland Clinic, pulmonary hypertension (PH) is a rare blood disease. In PH patients, arteries become more narrow, making it difficult for blood to flow through the vessels between the heart and the lungs, increasing the blood pressure in the pulmonary arteries. MORE: The difficulties of diagnosing pulmonary arterial hypertension…
Pulmonary hypertension cuts off blood flow to the lungs and parts of the heart. Some of the symptoms of the disease include fatigue, dizziness and difficulty breathing. For these and other reasons, active people find living with PH very difficult, and there are few people more active than children.
SteadyMed Therapeutics submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for Trevyent (treprostinil injection) in the treatment of pulmonary arterial hypertension (PAH), SteadyMed’s partner, Cardiome Pharma, recently announced. Trevyent is a drug-device combination that…
According to the Pulmonary Hypertension Association of Canada, pulmonary hypertension (PH) is a serious, progressive and potentially fatal lung disease. PH causes high blood pressure in the lungs due to inflammation or scarring in the pulmonary arteries. Untreated, PH can lead to weakness in the right side of the heart,…
There are various types of pulmonary hypertension (PH) but the root of the disease is the same. According to Living With PH and the NHS, the human body has several pulmonary arteries (blood vessels that take blood to your lungs). Pulmonary hypertension is what happens…
Icagen and Omdana Therapeutics are teaming up to develop treatments for pulmonary hypertension (PH) and other vascular remodeling diseases, and tissue disorders. At the heart of the collaboration will be a joint treatment discovery team. Omdana develops treatments for PH, whose hallmark is high blood pressure in the lung’s blood…
Pulmonary hypertension (PH) is a serious disease. As explained on healthline.com, pulmonary hypertension causes the blood pressure in the pulmonary arteries to become too high, resulting in shortness of breath, dizziness, fatigue and heart palpitations. Although there is no known cure, the symptoms can be treated through lifestyle changes,…
A new Pulmonary Hypertension Association awareness campaign is featuring singer Traci Braxton, who has two sisters with related diseases. The public service ads, an extension of a previous awareness effort, are in print, online, and on radio and television. One target will be commuters going in and out of Amtrak’s Northeast…
MannKind Corporation, which is developing the pulmonary arterial hypertension (PAH) therapy Treprostinil Technosphere, has retained the biopharmaceutical financing specialist Locust Walk to help it raise capital for Treprostinil and other projects. Locust Walk lines up investors and strategic partners for companies like MannKind, which also wants to use its Technosphere technology to develop…
A live, online mini-concert starring Chloe Temtchine has drawn thousands of viewers while raising awareness about pulmonary hypertension (PH), a progressive, life-threatening disease. The Facebook Live concert, presented recently by the Pulmonary Hypertension Association (PHA), attracted 1,500 live attendees and served as the finale for PHA’s World PH Day, the culmination…
Get regular updates to your inbox.